Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Colorcon
Healthtrust
Fuji
Cipla
Farmers Insurance
Cerilliant
Dow

Generated: June 23, 2018

DrugPatentWatch Database Preview

Indecainide hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for indecainide hydrochloride and what is the scope of indecainide hydrochloride freedom to operate?

Indecainide hydrochloride
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Synonyms for indecainide hydrochloride
73681-12-6
74517-78-5 (Parent)
9-(3-((1-Methylethyl)amino)propyl)-9H-fluorene-9-carboxamide hydrochloride
9-(3-(Isopropylamino)propyl)fluorene-9-carboxamide monohydrochloride
9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide hydrochloride
9-Carbamoyl-9-(3-isopropylaminopropyl)fluorene hydrochloride
9H-Fluorene-9-carboxamide, 9-(3-((1-methylethyl)amino)propyl)-, monohydrochloride
AC1L1CGJ
C20H24N2O.HCl
CHEMBL1200341
D04521
Decabid (TN)
DTXSID60223950
Indecainide HCl
indecainide hydro-chloride
Indecainide hydrochloride (USAN)
Indecainide hydrochloride [USAN]
LS-69204
LY 135837
M76V0B96L5
NXNSCUZKMVYAJQ-UHFFFAOYSA-N
SCHEMBL121201
UNII-M76V0B96L5

US Patents and Regulatory Information for indecainide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for indecainide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
UBS
Medtronic
AstraZeneca
Argus Health
Fuji
Chinese Patent Office
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.